Cisterna Magna CSF Cooling for Rapid Brain Hypothermia

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for cooling the brain during conditions of interrupted intracranial circulation, such as cardiac arrest or exsanguination, are inefficient, risky, and time-consuming, often leading to irreversible brain damage within minutes, necessitating a rapid and safe method to induce deep hypothermia and prevent brain death.

Innovation Solution

A system for directly cooling cerebrospinal fluid (CSF) by inserting a needle into the cisterna magna, using ultrasound guidance and a temperature-sensitive alloy tip to prevent tissue damage, combined with a recirculating cooling method that includes convection cooling and a closed sterile system for rapid brain temperature reduction.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Temperature

If conventional cooling methods (cardiopulmonary bypass, subclavian artery cooling) are used to cool the brain, then brain temperature can be reduced to prevent ischemic damage, but the procedure is time-consuming and requires complex surgical intervention that may not be feasible within the critical time window

Engineering Contradiction:
Improvebrain temperatureVSAvoidtime to induce hypothermia
Core Design Contradiction:
TemperatureVSLoss of time

Solution Approach 1:

The patent extracts the cooling function from the systemic circulation system and places it directly into the cerebrospinal fluid system. By inserting a catheter into the cisterna magna and infusing cooled saline directly into the subarachnoid space, the cooling action is separated from the complex cardiopulmonary bypass system, enabling rapid localized brain cooling without requiring systemic surgical intervention

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses cooled saline as an intermediary substance to transfer thermal energy from the cooling device to the brain tissue. The saline acts as a heat sink that absorbs heat from the brain through the cerebrospinal fluid, enabling indirect cooling that is both rapid and controllable without direct contact between the cooling device and brain tissue

Inventive Principle:
Principle #24Intermediary (Mediator)

2Duration of action of moving object

If deep hypothermia is induced rapidly to protect the brain during circulatory arrest, then brain function can be preserved for extended periods, but the risk of tissue damage from rapid cooling and needle insertion increases

Engineering Contradiction:
Improveduration of brain protectionVSAvoidtissue damage from cooling procedure
Core Design Contradiction:
Duration of action of moving objectVSObject-affected harmful factors

Solution Approach 1:

The patent performs preliminary actions to ensure safety before the main cooling procedure. Ultrasound guidance is used to pre-identify the optimal insertion path and avoid critical structures. The needle is inserted under real-time imaging control, and the cooling infusion rate is gradually increased to allow tissue adaptation, preventing thermal shock and mechanical damage

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent implements continuous feedback control through real-time monitoring of brain temperature using thermocouples or temperature-sensitive indicators visible under ultrasound. This feedback allows dynamic adjustment of the cooling saline flow rate and temperature to maintain the brain within the optimal hypothermic range (10-20°C) without causing freezing or excessive cold damage to surrounding tissues

Inventive Principle:
Principle #23Feedback

3Reliability

If mild to moderate hypothermia (33°C) is used to treat ischemic brain damage, then some brain protection is achieved, but the protection is insufficient for extended circulatory arrest and systemic complications still occur

Engineering Contradiction:
Improvebrain protection efficacyVSAvoidapplicability to extended arrest periods
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent changes the temperature parameter from mild-moderate hypothermia (33°C) to profound hypothermia (10-20°C) by controlling the temperature of the infused saline and the duration of infusion. This parameter change transforms the level of protection from insufficient to adequate for extended circulatory arrest, while the localized application method allows this extreme cooling without causing systemic complications

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables rapid induction of deep hypothermia, protecting the brain from death by maintaining it in a state of suspended animation for up to one hour, allowing time for medical intervention and reducing the risk of systemic complications.

Implementation Method 1

using ultrasound guidance and a temperature-sensitive alloy tip to prevent tissue damage

Methodology Applied
Scientific EffectTemperature-sensitive alloy: Shape Memory Alloy

Implementation Method 2

combined with a recirculating cooling method that includes convection cooling and a closed sterile system for rapid brain temperature reduction

Methodology Applied
Scientific EffectConvection cooling: Convection

Data Source

PatentEP4034054B1Device to cool the brain and to diagnose and treat glioblastoma
Publication Date: 2026.03.04 WONG EDWARD
  • EP4034054B1 patent drawingFigure 1
  • EP4034054B1 patent drawingFigure 2
  • EP4034054B1 patent drawingFigure 3~4

AI summary

A method, and apparatus used to prevent brain death by use of rapid and safe cooling of the brain is disclosed. The cisterns magna is accessed through a patient's neck and cooled artificial cerebrospinal fluid (aCSF) is circulated about spaces within the brain and in a subarachnoid space surrounding the brain by entering the cisterna magna with an entry through the neck of the patient with a specially designed needle/cannula which allows the flow of cooled aCSF about the brain. aCSF exits from an opening in the skull where a temperature/pressure sensor is placed. Data is sent to a computer-controlled motorized system that pumps cooled aCSF to the needle/cannula placed in the cisterna magna. The pumping of aCSF is controlled to maintain a predetermined temperature and/or pressure of the exiting aCSF.